Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
Fibrinogen-related cellular receptors and signaling molecules in the CNS. Fibrinogen plays a critical role in neuroinflammation, neurodegeneration, and myelin damage by binding to receptors on various cells within the nervous system. The interactions with astrocytes, neurons, microglia, OLs, and Schwann cells trigger downstream signaling pathways that worsen neuroinflammatory processes, oxidative stress, and cellular demise. Specifically, when fibrinogen binds to astrocytes, it activates the Smad pathway. This activation leads to the release of inflammatory factors and suppression of neurite growth. Similarly, binding to neurons activates the EGFR, inhibiting neurite growth, and triggers the NF-κB pathway, upregulating the levels of CCL2 and IL6, which result in neuronal death. During its conversion to fibrin, fibrinogen exposes the γ377–395 epitope. This epitope binds to the CD11b/CD18 integrin receptor on microglia, promoting the release of ROS and NO, triggering the signaling cascade of the Akt, RhoA, and PI3K pathways, and increasing the levels of CCL2 and CXCL10. Activation of these signaling molecules exacerbates neuroinflammation and demyelination. Furthermore, fibrinogen’s interaction with OLs increases phosphorylation of the BMP signal transducers Smad1/5, impeding myelin regeneration. Its interaction with Schwann cells, on the other hand, stimulates the ERK pathway, also impeding myelin regeneration. P-Smad, phosphorylated mad homolog; P-EGFR, phosphorylated epidermal growth factor receptor; P-Akt, phosphorylated serine/threonine-protein kinase; The integrin receptors: αvβ3, αvβ8; ACVR1, activin A receptor type 1; NF-κB, nuclear factor-κB.